Letter From the Commissioner’s Office at the US FDA John A. Vernon Editorial 22 September 2012 Pages: 267 - 268
Measuring Patient-Reported Outcomes in Solid Organ Transplant Recipients Irina CleemputFabienne Dobbels Leading Article 22 September 2012 Pages: 269 - 286
The Economic Implications of Glaucoma Jordana K. SchmierMichael T. HalpernMechelle L. Jones Review Article 22 September 2012 Pages: 287 - 308
Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer Steven B. ZeliadtDavid F. Penson Review Article 22 September 2012 Pages: 309 - 327
Cost Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox versus Infusional Deferoxamine in Transfusion-Dependent Thalassaemia Patients Thomas E. DeleaOleg SofryginThomas D. Coates Review Article 22 September 2012 Pages: 329 - 342
Therapeutic Use of Granulocyte Colony-Stimulating Factors for Established Febrile Neutropenia Leon E. CoslerAdi Eldar-LissaiGary H. Lyman Review Article 22 September 2012 Pages: 343 - 351
Measuring and Valuing Health Benefits for Economic Valuation Christopher I. Carswell Book Review 22 September 2012 Pages: 353 - 353